Dow Down 0.09% Nasdaq Up 0.25%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
43.19 Up 0.69(1.62%) 1:07PM EDT - Nasdaq Real Time Price
Prev Close:42.50
Open:42.50
Bid:43.10 x 200
Ask:43.15 x 100
1y Target Est:44.75
Beta:1.29
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:41.51 - 43.32
52wk Range:32.35 - 55.99
Volume:472,717
Avg Vol (3m):1,034,560
Market Cap:5.33B
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENUp 1.62%5.33B
IMGNUp 0.52%991.01M
PFEUp 0.45%183.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-6.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback